Area of research
Oncology · Cancer Research
Research interest
Research focused on Gemcitabine and Oncology, with related work in Pancreatic cancer, Sunitinib, Chemotherapy-induced peripheral neuropathy. Notable publications include 'Increased Survival in Pancreatic Cancer with nab-Paclitaxel plus Gemcitabine', 'Pancreatic Cancer hENT1 Expression and Survival From Gemcitabine in Patients From the ESPAC-3 Trial', and 'Cancer-Related Fatigue in Women With Breast Cancer: Outcomes of a 5-Year Prospective Cohort Study'.
Ripretinib versus sunitinib in gastrointestinal stromal tumor: ctDNA biomarker analysis of the phase 3 INTRIGUE trial
Validity of Patient-Reported Outcome Measures in Evaluating Nerve Damage Following Chemotherapy
Phase Ib open-label, multicenter study of pixatimod, an activator of TLR9, in combination with nivolumab in subjects with microsatellite-stable metastatic colorectal cancer, metastatic pancreatic ductal adenocarcinoma and other solid tumors
Increased Survival in Pancreatic Cancer with nab-Paclitaxel plus Gemcitabine
Pancreatic Cancer hENT1 Expression and Survival From Gemcitabine in Patients From the ESPAC-3 Trial
Cancer-Related Fatigue in Women With Breast Cancer: Outcomes of a 5-Year Prospective Cohort Study